# India Oral Contraceptive Pills Market (2023-2029) --- ## Report Summary The India Oral Contraceptive Pills Market report covers companies, competitive trends, segmentation, demand growth and industry outlook across 2020-2031. --- ## India Oral Contraceptive Pills Market Report Table of Content Table of Content - 1. India Oral Contraceptive Pills Market Overview - 1.1. Market Highlights - 1.2. India Oral Contraceptive Pills Market Taxonomy - 2. India Oral Contraceptive Pills Market Ecosystem - 3. India Oral Contraceptive Pills Market Size (in USD Bn), 2019-2023 - 4. India Oral Contraceptive Pills Market Segmentation, 2023 - 4.1. India Oral Contraceptive Pills Market Segmentation by Product Type (in USD Mn), 2023 - 4.2. India Oral Contraceptive Pills Market Segmentation by Demography (in USD Mn), 2023 - 4.3. India Oral Contraceptive Pills Market Segmentation by Formulation (in USD Mn), 2023 - 4.4. India Oral Contraceptive Pills Market Segmentation by Distribution Channel (in USD Mn), 2023 - 4.5. India Oral Contraceptive Pills Market Segmentation by Region (in USD Mn), 2023 - 5. India Oral Contraceptive Pills Market Competitor Analysis - 5.1. India Oral Contraceptive Pills Market Company Profile - 5.2. India Oral Contraceptive Pills Market Players Cross-Comparison, 2022 - 6. India Oral Contraceptive Pills Industry Analysis - 6.1. Growth Drivers in India Oral Contraceptive Pills Market - 6.2. Challenges in India Oral Contraceptive Pills Market - 6.3. India Oral Contraceptive Pills Market Porters 5 Forces - 7. India Oral Contraceptive Pills Future Market Size (in USD Bn), 2023-2029 - 8. India Oral Contraceptive Pills Market Macro Indicators - 8.1. India GDP and Inflation Rate, 2013-2023 - 8.2. India’s literacy rate, 1951-2011 - 8.3. India’s Internet Penetration Rate 2007-2022 - 9. India Oral Contraceptive Pills Market Research Methodology - 9.1. India Oral Contraceptive Pills Market Definitions - 9.2. India Oral Contraceptive Pills Market Sizing Approach - 9.3. India Oral Contraceptive Pills Market Consolidated Research Approach --- ## India Oral Contraceptive Pills Market Overview India Oral Contraceptive Pills Market Highlights The India Oral Contraceptive Pills Market was valued at USD 463.2 Mn in 2017 and grew at a CAGR of 6.5% during 2017–2023. The market is further expected to reach USD 1062.5 Mn by 2029, expanding at a projected CAGR of 7.9% over 2023–2029. The industry remains moderately fragmented, with the presence of several large and established players operating in the market. Future growth is expected to be driven by increasing awareness around women’s health and gynecological care, along with continued efforts to control total fertility rate (TFR) and manage population growth in the country. *The India Oral Contraceptive Pills Market, valued at USD 463.2 Mn in 2017, grown with a Compound Annual Growth Rate (CAGR) of 6.5% from 2017 to 2023.* --- ## Taxonomy | ID | Parent ID | Label | | --- | --- | --- | | 1 | | Indian Oral Contraceptive Pills Market | | 2 | 1 | Type | | 3 | 1 | Demography | | 4 | 1 | Formulation | | 5 | 1 | Distribution Channels | | 6 | 1 | Region | | 7 | 2 | Combined Oral Contraceptives | | 8 | 2 | Emergency Contraceptive Pills | | 9 | 3 | Rural | | 10 | 3 | Urban | | 11 | 4 | Monophasic Pills | | 12 | 4 | Multiphasic Pills | | 13 | 4 | Extended Cycle Pills | | 14 | 5 | Prescription-based | | 15 | 5 | Over-the-counter (OTC) | | 16 | 6 | North | | 17 | 6 | West | | 18 | 6 | East | | 19 | 6 | South | --- ## India Oral Contraceptive Pills Market Ecosystem ### Market Ecosystem **Ecosystem of India Oral Contraceptive Pills** --- ## India Oral Contraceptive Pills Market Size (in USD Mn), 2017-2023 India’s Oral Contraceptive Pills (OCP) market recorded steady growth at a CAGR of 6.5% during 2017–2023, reaching a market value of USD 674.9 Mn. This expansion was driven by the rising adoption of contraceptive pills as a method of birth control, with usage increasing from around 4% in 2018 to over 5% in 2021. Market growth was further supported by proactive government measures that improved awareness and expanded the availability of pills at subsidized prices, making them more accessible and affordable. In addition, rising internet and mobile penetration across the country has played an important role in spreading awareness about contraceptive methods and the prevention of unwanted pregnancies. The market has also benefited from the broader global push toward family planning under the Sustainable Development Goals, where contraception is recognized as an important tool for moderating population growth. --- ## India Oral Contraceptive Pills Market Segmentation, 2023 ### India Oral Contraceptive Pills Market by Product Type (in revenue %), 2023 The Oral Contraceptive Pills market is primarily segmented into Combined Oral Contraceptives (COC) and Emergency Contraceptive Pills (ECP), with COC dominating the market with a substantial 81.2% share, valued at USD 548.4 Mn. In contrast, ECP accounts for the remaining 18.8% share, valued at USD 126.5 Mn. The relatively lower share of ECP is due to the potential side effects associated with its use, especially as it is consumed within 72 hours of unprotected sexual activity and excessive use may lead to serious health complications. Both COC, including POP, and ECP are hormonal contraceptives, but COC is typically taken on a regular 21- or 28-day basis depending on the menstrual cycle and physician guidance. The strong market position of COC is driven by its high contraceptive efficacy, predictable daily usage, and additional health-related benefits beyond contraception. ### India Oral Contraceptive Pills Market by regional demography (in revenue %), 2023 The Urban-Rural segmentation of the India OCP Market presents an interesting pattern, with Rural India accounting for the larger share at 54.5%, valued at USD 368.1 Mn, while Urban India represents the remaining 45.5%, valued at USD 306.8 Mn. This dominance of rural demand is not driven by stronger healthcare, education, or economic conditions, but rather by targeted government interventions that have improved accessibility and affordability. Initiatives such as Jan Aushadhi Kendras have expanded the availability of low-cost contraceptive pills, while awareness campaigns led by ASHA workers through door-to-door outreach have strengthened adoption in rural areas. In addition, government subsidies have further supported affordability. In contrast, although urban regions benefit from better healthcare infrastructure, education, economic conditions, and greater confidentiality, consumers there often prefer alternative contraceptive methods over oral contraceptive pills. --- ## India Oral Contraceptive Pills Industry Analysis ### India Oral Contraceptive Pills Market Growth Drivers **Government Initiatives** Indian Government at both center and state level has undertaken various initiatives for female health and well-being and also to promote family planning. Community-based distribution: Making oral contraceptives available through community-based distribution channels, such as Accredited Social Health Activists (ASHAs), through GOI National Health Mission and other programs have encouraged people to promote family planning methods, including OCPs. Improved healthcare infrastructure: In 2022-2023, government allotted Rs 86,000 crore, whereas in 2023-2024 government allotted Rs86,175 crores to healthcare, expenditure has been increasing over the years. As healthcare infrastructure improves, access to contraceptives becomes more widespread **Economic growth** As India's economy grows, women may have greater access to education and employment, which can lead to increased awareness and acceptance of modern contraceptive methods. Currently, female literacy rate in India is 65.38%, while the male literacy rate is 82.14%. **Investment in R&D Activities** Key players in the home appliances market are heavily investing in research and development (R&D) to maintain a competitive edge. The focus on technology standards and innovative product development through effective R&D processes has seen a significant uptick in investment over the past few years. ### India Oral Contraceptive Pills Market Challenges **Cultural and social issues** Restrictions on contraceptive use in certain areas due to cultural, religious, and social norms. This stems from social stigma against Contraceptive use, particularly in early marriage or unmarried, historically reinforced non-use as well. Socio-cultural concerns related to prescribed social roles of motherhood as well as expectations regarding childbirth, son preference, and family size are major issues preventing spacing Contraceptive use and continue to disproportionately affect rural women. **Access to healthcare services** Variable availability of healthcare services, especially in rural areas, which may restrict access to family planning services and contraceptives. For instance, World Health Organization (WHO) recommends a minimum doctor-population ratio of 1:1,000, however India in 2017 it was 1.34 doctors per 1000 population, which is further expected to improve to 1.03 in 2024. **Side effects and cost** Side effects associated with using contraceptives such as nausea, severe crams, dizziness among other are common, further fear of high cost of treatment leading to huge out of pocked expenditure may impede the market's growth. ### India Oral Contraceptive Pills Market Porters 5 Forces **Threat of Substitutes** Moderate, as new pills are being invented with reduced side effects **Bargaining Power of Suppliers** Moderate due to multiple suppliers, and government further taking steps to ensure ease of business. **Rivalry** High due to intense competition, frequent innovation, and rapid technological advancements **Bargaining Power of Buyers** Due to efforts of government (subsidizing OCP). Also influenced by physician or popular peer choice, however brand loyalty persists. **Threat of New Entrants** Moderate, as setting up a pharmaceutical industry require investment as well as adherence to numerous regulations. --- ## India Oral Contraceptive Pills Market Company Profile | Year | Company | Description | | --- | --- | --- | | 1995 | Mankind | Mankind is a public pharmaceutical company headquartered in Delhi. It is Largest pharmaceutical company of India (by sales), generating a revenue of INR 87.49 Bn (2023). Its revenue from the Oral Contraceptive Market (under gynecology) in India contributes to its overall revenues along with its other offerings, but it is not a key revenue stream for the company. | | 1935 | Cipla | Cipla is the Indian multinational public pharmaceutical company headquartered in Mumbai. With its presence in over 80 countries, making 1500 products available, Cipla generated a total revenue of INR 227 Bn (2023). Its revenue from the Oral Contraceptive Market (under gynecology) in India contributes to its overall revenues along with its other offerings, but it is not a key revenue stream for the company. | | 1983 | Sun Pharma | Sun Pharmaceutical Industries Limited is the Indian multinational public pharmaceutical company headquartered in Mumbai. With its presence in over 80 countries, Sun Pharma generated a total revenue of INR 445.2 Bn (2023). Its revenue from the Oral Contraceptive Market (under gynecology) in India contributes to its overall revenues along with its other offerings, but it is not a key revenue stream for the company. | | 2020 | Piramal Pharma | Piramal is the Indian multinational public pharmaceutical company headquartered in Mumbai. With its distribution facilities in over 100 countries, Piramal Pharma generated a total revenue of INR 147.1 Bn (2023). Its revenue from the Oral Contraceptive Market (under gynecology) in India contributes to its overall revenues along with its other offerings, but it is not a key revenue stream for the company. | | 1952 | Zydus | Zydus Lifesciences Ltd, earlier known as Cadilla Healthcare Ltd. is the Indian multinational public pharmaceutical company headquartered in Ahmedabad. With its distribution facilities in over 50 countries, Piramal Pharma generated a total revenue of INR 2.51Bn (2023). Its revenue from the Oral Contraceptive Market (under gynecology) in India contributes to its overall revenues along with its other offerings, but it is not a key revenue stream for the company. | --- ## India Oral Contraceptive Pills Future Market Size ### India Oral Contraceptive Pills Future Market Size (in USD Mn), 2023-2029 Looking ahead, the India OCP Market is expected to witness strong growth, with forecasts indicating a steady CAGR of 7.9% from 2023 to 2029F, taking the market value to USD 1,062.5 Mn by 2029F. This growth is likely to be supported by government-run schemes, continued efforts toward population control beyond the SDG 2030 agenda, wider awareness through modern technology, and rising investment in health infrastructure. In addition, several states, including Uttar Pradesh, are introducing schemes that encourage population control by promoting the adoption of birth control methods across communities, which is expected to further support market expansion. --- ## India Oral Contraceptive Pills Market Macro Indicators ### India GDP and Inflation Rate (in USD Tn and %), 2013-2023 India’s GDP has experienced an Increasing growth to USD 3.7 Trillion in 2023, with a decline during pandemic financial year. And decline in inflation further points to increase in purchasing power of the people, both lead to increase in the real income for the people, spilling over to more productive activities such as education and health. ### India’s Literacy Rate (in %), 1951-2011 Latest census data (2011) points towards over 73% literacy rate for the whole nation with female lagging at ~65%. But the rate for female literacy has increased to over 70% in a recent report by NSO. Educating people, particularly woman would lead to increase in awareness about the pertaining issues, including Population control and family planning. ### India’s Internet Penetration Rate (in %), 2007-2022 India has over 692.0 million internet users with mobile penetration rate is anticipated to be over 85% in 2026, this would lead to access to information without outside help, and to remote places in India. Awareness about family planning would further lead to awareness about OCP and other pregnancy preventive methods, fueling India’s journey to surpassing SDG. --- ## Frequently Asked Questions Find quick answers to common questions about the India Oral Contraceptive Pills Market **Q: At what rate India Oral Contraceptive Pills Market would grow in future?** A: India OCP Market is anticipated to grow ~ 8% CAGR in the future (2023-2029). **Q: Which type of OCP is preferred more by Indian women?** A: The COC segment (including POP) is preferred more over ECP(Emergency contraception pills). **Q: Who should not take oral contraceptives?** A: Women with certain medical conditions, such as blood clots, heart disease, or liver disease, should not use oral contraceptive. **Q: What are the side effects associated with oral contraceptives?** A: Common side effects of oral contraceptives include breast tenderness, nausea, and spotting between menstrual cycles after the first regimen. **Q: What are the reasons for using contraceptive pills?** A: Women use contraceptive pills for various reasons, including preventing unwanted pregnancy, regulating periods, easing menstrual cramps, and clearing up skin, however, consultation with the doctor is advised before beginning the usage.